The treatment of cerebral origin spasticity in children

NeuroRehabilitation

Volumn 12, Issue 2, 1999, Pages 93-103

  Gormley, Mark E ^a,b,c  

^a GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Botulinum toxin; Cerebral palsy; Intrathecal baclofen pump; Phenol; Selective dorsal rhizotomy; Spasticity

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; DANTROLENE; DIAZEPAM; PHENOL; TIZANIDINE;

ADOLESCENT; BRACE; BRAIN INJURY; CASE REPORT; CEREBRAL PALSY; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; DORSAL RHIZOTOMY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MALE; OCCUPATIONAL THERAPY; ORAL DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; PHYSIOTHERAPY; PRESCHOOL CHILD; REVIEW; SPASTICITY;

EID: 0032793711     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-1999-12203     Document Type: Review

References (50)

1. Albright, AL, Barry, M, Fasick, P, Barron, W and Shultz, B, Continuous Intrathecal Baclofen Infusion for Symptomatic Generalized Dystonia, Neurosurgery 38(5) (1996), 934-939.
2. Albright, AL, Barron, W, Fasick, M, Polinko, P and Janosky, J, Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin, JAMA 270(20) (1993), 2475-2477.
3. Albright, AL, Barry, M and Schultz, B, Continuous Intrathecal Baclofen For Generalized Dystnnia. Children's Hospital of Pittsburgh, 1996.
4. Bensman, A and Szegho, M, Cerebellar electrical stimulation: a critique, Arch Phys Med Rehabil 59 (1978), 485-487.
5. Chambers, H, The Surgical Treatment of Spasticity, Muscle Nerve Supplement 6 (1997), 121.
6. Cooper, I, Riklan, M, Amin, I, Waltz, J and Cullinan, T, Chronic cerebellar stimulation in cerebral palsy, Neurology 26(8) (1976), 744-753.
7. Cosgrove, A, Corry, I and Graham, J, Botulinum toxin in the management of the lower limb in cerebral palsy (Class C), Dev Med Child Neurol 36 (1994), 386-396.
8. Davis, R, Barolat-Romana, G and Engle, G, Chronic cerebellar stimulation for cerebral palsy-five year study, Acta Neurochir Suppl 30 (1980), 317-332.
9. Easton, J, Ozel, T and Halpern, D, Intramuscular neurolysis for spasticity in children, Arch Phys Med Rehabil. 60 (1984), 156-158.
10. Engle, H, The effect of diazepam (Valium) in children with cerebral palsy: A double-blind study, Dev Med Child Neurol 8(1966), 661-667.
11. Fasano, V, Barolat-Romana, G, Ivaldi, A and Sguazzi, A, Functional posterior radiculotomy, in the treatment of cerebral spasticity. Perioperative electric stimulation of posterior roots and its use in the choice of the roots to be sectioned, Neuro-Chirurgie bf 22 (1976), 23-34.
12. Forster, O, Uber eine neue operative method der Behadlung spastischer Lahmunger mittels Resektion hinterer Ruckenmarks Wurzeln, Z Orthop Chir 22 (1908), 203-223.
13. Glenn, M, Nerve Blocks, in: The Practical Management of Spasticity in Children and Adults, M. Glenn and J. Whyte, eds., Philadelphia. Lea and Febiger, 1990, pp. 230.
14. Gracies, J, P, N, Elovic, E, McGuire, J and Simpson, D, Traditional Pharmacological Treatments for Spasticity Part II: General and Regional Treatments, Muscle Nerve 6 (1997), S100.
15. Greene, M, Ed., The Harrient Lane Handbook, St. Louis, MO, Mosby Year Book, 1996.
16. Harris, S and Riffle, K, Effects of inhibitive ankle-foot orthoses on standing balance in a child with cerebral palsy, Physical Therapy 66(5) (1986), 663-667.
17. Haslam, R, Walcher, J, Lietman, P, Kallman, C and Mellits, E, Dantrolene sodium in children with spasticity, Arch Phys Med Rehabil. 55 (1974), 384-388.
18. Ivan, L, Ventureyra, E, Wiley, J, Doyle, D, Pressman, E, Knights, R, Guzman, C and Uttley, D, Chronic cerebellar stimulation in cerebral palsy, Surg Neurol 15 (1981), 81-84.
19. Kao, I, Drachman, D and Price, D, Botulinum toxin: mechanism of presynaptic blockade, Science 193 (September 1976), 1256-1258.
20. Koman, L, Mooney, J d, Smith, B, Goodman, A and Mulvaney, T, Management of cerebral palsy with botulinum A toxin: preliminary investigation (Class C), J Ped Ortho 13 (1993), 489-495.
21. Kriel, R, Krach, L, Hoff, D, Gormley, M and Jones-Saete, C, Failure of Absorption of Baclofen After Rectal Administration, Pediatr Neurol 16(4) (1997), 351-352.
22. Lapierre, Y, Bouchard, S, Tansey, C, Gendron, D, Barkas, W and Francis, G, Treatment of spasticity with tizanidine in multiple sclerosis, Can J Neurol Sci 14 (1987), 513-517.
23. Leach, J, Children Undergoing Treatment with Botulinum Toxin: The Role of the Physical Therapist, Muscle Nerve 6 (1997), S194-207.
24. Little, J and Merritt, J, Spasticity and associated abnormalities of muscle tone. Rehabilitation medicine principles and practice, J. DeLisa. Philadelphia, JB Lippincott. (1988), 430-447.
25. Logigian, E, Wolinsky, J, Soriano, S, Madsen, J and Scott, R, H Reflex Studies in Cerebral Palsy Patients Undergoing Partial Dorsal Rhizotomy, Muscle Nerve 5 (1994), 539-549.
26. Mahajan, D and Desiraju, T, Alterations of dendritic branching and spine density of hippocampal CA3 pyramidal neurons induced by operant conditioning in the phase of brain growth spurt, Experimental Neurology 100 (1988), 1-15.
27. McLaughlin, J, Bjornson, K, Price, R, Astley, S, Hays, R and Roberts, T, Efficacy of Selective Dorsal Rhizotomy in Cerebral Palsy: Changes in Spasticity and Neurologic Signs after 12 Months, Dev Med Child Neurol 38 Supplement 74(8) (1996), 33.
28. Molnar, P, Ed., Pediatric Rehabilitation Second Edition, Baltimore, Williams and Wilkins, 1992.
29. Morrison, J, Matthews, D, Washington, R, Fennessey, P and Harrison, L, Phenol Motor Point Blocks in children: Plasma Concentrations and Cardiac Dysrhythmias, Anesthesiology 75 (1991), 359-362.
30. Novacheck, T, personal communication, Medical Director of Motion Laboratory, Gillette Children's Specialty Healthcare, St. Paul, Minnesota. 1998.
31. Odeen, I, Reduction of muscular hypertonus by long-term muscle stretch, Scand J Rehabil Med 13 1981), 93-99.
32. O'Dwyer, N, Neilson, P and Nash, J, Mechanisms of muscle growth related to muscle contracture in cerebral palsy, Dev Med Child Neurol. 31 (1989), 543-547.
33. Peacock, W and Arens, L, Selective posterior rhizotomy for the relief of spasticity in cerebral palsy, So Afr Med J 62 (1982), 119-124.
34. Peacock, W and Staudt, L, Spasticity in cerebral palsy and the selective posterior rhizotomy procedures, J Child Neurol 5 (1990), 179-185.
35. Reisman, M and BM, G, Hallucinations association with acute baclofen withdrawal: report of two pediatric cases, Kansas City, MO, 47th Annual Asssembly of the American Academy of Physical Medicine and Rehabilitaiton, 1997.
36. Rosales, R, Arimura, K, Takenaga, S and Osame, M, Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection, Muscle Nerve 19 (1996), 488-496.
37. Russman, B, Tilton, A and Gormley, M, Cerebral Palsy: A Rational Approach to a Treatment Protocol, and the Role of Botulinum Toxin in Treatment, Muscle Nerve 6 (1997), S181-193.
38. Schantz, E and Scott, A, Use of crystalline type A botulinum toxin in medical research, in: Biomedical aspects of botulism, G. Lewis, ed., New York, Academic Press, 1981, pp. 143-150.
39. Scott, A and Suzuki, D, Systemic Toxicity of Botulinum Toxin by Intramuscular Injection in the Monkey, Mov Disord 9(2) (1988), 213-217.
40. Speelman, D and van Manen, J, Cerebral palsy and sterotactic neurosurgery: long term results, J Neurol Neurosurg Psychiatry 52 (1989), 23-30.
41. Spira, R, Management of spasticity in cerebral palsied children by peripheral nerve block with phenol, Dev Med Child Neurol 13 (1971), 164-173.
42. Steinbok, P, Reiner, A, Beauchamp, R, Armstrong, R, Cochrance, D and Kestle, J, Randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy, Dev Med Child Neurol 39 (1997), 178-184.
43. Stempien, L and Gaebler-Spira, D, Rehabilitation of Children and Adults with Cerebral Palsy, in: Physical Medicine and Rehabilitation, R.L. Braddom, ed., Philadelphia, WB Saunders, 1996, pp. 1113-1132.
44. Stout, J, Gormley, M, Koop, S, Quanbeck, D, Krach, L, Abramowitz, A and Dunn, M, The Effects of Selective Dorsal Rhizotomy on Oxygen Consumption and Gait Velocity in Children with Cerebral Palsy, Dev Med Child Neurol 1997 Abstracts, (1997), 14.
45. Sutherland, D, Kaufman, K, Wyatt, M and Chamber, H, Injection of botulinum A toxin into gastrocnemius muscle of patients with cerebral palsy: a 3D motion analysis study (Class A), Gait & Posture 4(4) (1996), 269-279.
46. Taggart, P and Matthews, D, Eds., Pediatric Rehabilitation, Second Edition, Rehabilitation Medicine Library, Baltimore, Williams and Wilkins, 1992.
47. Traboulsi, E and Maumenee, I, Eye Problems, Principles and Practice of Pediatrics, M.D. Frank A Oski, Philadelphia, PA, JB Lippincott, 1990, Chapter 34.
48. Ward, A, Chaffman, M and Sorkin, E, Dantrolene: a review of its pharmacolkinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity, Drugs 32 (1986), 130-168.
49. Whyte, J and Robinson, K, Pharmacologic Management, The Practical Management of spasticity in Children and Adults, Philadelphia, Lea and Febiger, 1990, 209.
50. Wood, K, The use of phenol as a neurolytic agent: A review, Pain 5 (1978), 205-229.